◀ Back to IL33

CD14 — IL33

Text-mined interactions from Literome

Iwagaki et al., Infect Immun 2000 : The purpose of this study was to compare and contrast the endotoxin neutralizing activities of two synthetic antiendotoxin peptides ( SAEP-2 and SAEP-4 ), PMB, and an LPS core-specific monoclonal antibody ( MAb ), WN1 222-5, based on their abilities to inhibit CD14 mediated target cell uptake of fluorescein isothiocyanate ( FITC ) -conjugated LPS, detected by flow cytometry and confocal microscopy, and LPS induced production of the proinflammatory cytokines, interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-alpha), as measured by bioassays
Espinassous et al., J Immunol 2009 (Inflammation) : Our results show that IL-33 increases the expression of the LPS receptor components MD2 ( myeloid differentiation protein 2 ) and TLR-4, the soluble form of CD14 and the MyD88 adaptor molecule